Suppr超能文献

难溶性药物在甘油三酯脂质中混悬液制剂的体外消化过程中的药物增溶行为。

Drug solubilization behavior during in vitro digestion of suspension formulations of poorly water-soluble drugs in triglyceride lipids.

作者信息

Kaukonen Ann Marie, Boyd Ben J, Charman William N, Porter Christopher J H

机构信息

Department of Pharmaceutics, Victorian College of Pharmacy, Monash University (Parkville Campus), Parkville, Victoria 3052, Australia.

出版信息

Pharm Res. 2004 Feb;21(2):254-60. doi: 10.1023/b:pham.0000016283.87709.a9.

Abstract

PURPOSE

The purpose of this study was to characterize the solubilization and precipitation characteristics of a range of poorly water-soluble drugs during the in vitro digestion of long-chain or medium-chain triglyceride (TG) lipid suspension formulations.

METHODS

TG suspensions of model drugs (present at double their equilibrium solubilities in the respective lipid) were digested in vitro and the drug solubilization and precipitation pattern in the resulting digests analyzed.

RESULTS

For griseofulvin, diazepam, and danazol, solubilization of the small mass of drug originally presented in the TG lipid was efficient with only a small proportion of the dose precipitating and being recovered in the pellet phase after digestion of the TG lipid. For the more lipophilic and lipid-soluble drugs (cinnarizine, halofantrine), in which higher drug loadings were possible, significant enhancement in drug solubilization in the postdigestion aqueous phase was not apparent compared with simple TG lipid solutions.

CONCLUSIONS

Suspensions of drugs, which are poorly soluble in water and TG lipid, may prove beneficial as the relatively high solubilizing capacity of the colloidal phases produced on TG digestion will likely exceed the mass of drug that could have been administered as a simple lipid solution. However, for more lipid-soluble drugs, suspension formulations may offer little benefit as sufficiently high drug loadings can otherwise be achieved with simple solution formulations that still provide for adequate solubilization after TG digestion.

摘要

目的

本研究旨在表征一系列难溶性药物在长链或中链甘油三酯(TG)脂质混悬液制剂体外消化过程中的增溶和沉淀特性。

方法

将模型药物的TG混悬液(药物含量为其在相应脂质中平衡溶解度的两倍)进行体外消化,并分析所得消化液中药物的增溶和沉淀模式。

结果

对于灰黄霉素、地西泮和达那唑,最初存在于TG脂质中的少量药物增溶效果良好,TG脂质消化后只有一小部分剂量沉淀并在沉淀相中回收。对于亲脂性和脂溶性更高的药物(桂利嗪、卤泛群),由于可以实现更高的药物负载量,与简单的TG脂质溶液相比,消化后水相中药物增溶的显著增强并不明显。

结论

难溶于水和TG脂质的药物混悬液可能是有益的,因为TG消化产生的胶体相相对较高的增溶能力可能会超过以简单脂质溶液形式给药的药物量。然而,对于脂溶性更高 的药物,混悬液制剂可能益处不大,因为通过简单溶液制剂可以实现足够高的药物负载量,并且在TG消化后仍能提供足够的增溶作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验